Blood tests for cyclic adenosine monophosphate may be a simple and useful option for diagnosing asthma and determining its ...

Depemokimab is a follow-up to GSK's Nucala (mepolizumab), a once-monthly IL-5 inhibitor approved for severe asthma, CRSwNP, ...

Emphysema is a chronic lung condition that affects millions of people worldwide and can make everyday activities such as ...

Researchers at McMaster University have made an important discovery in the field of asthma research, identifying a new population of immune cells that may play a crucial role in the severity of asthma ...

China was forced to put emergency measures in place earlier this month after the virus, later identified as HMPV, started to ...

This suggests that controlling intermediate ILC2 levels could keep counts of troublesome white blood cells down, thus potentially preventing severe asthma symptoms, the team said.

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- A set of chameleon-like immune cells could be contributing to severe asthma in ...

A spike in asthma-related hospitalisations is expected as children flock through school gates for the start of a new year.